Page 454 - medicina-integrativa_compress

CAPÍTULO 40 DISLIPIDEMIAS 455

BIBLIOGRAFÍA 25. Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil,
omega-3 fatty acids, and cardiovascular disease. Circulation 106:
1. National Cholesterol Education Panel Adult Treatment Panel III 2747-2757, 2002.
Expert Panel (including PE McBride): Third Report of the National 26. Kris-Etherton PM, Harris WS, Appel LJ: Omega-3 fatty acids
Cholesterol Education Program (NCEP) Expert Panel on detection, and cardiovascular disease: New recommendations from the
evaluation, and treatment of high blood cholesterol in adults (Adult American Heart Association, Arterioscler Thromb Vasc Biol 23:
Treatment Panel III). Circulation 106:3143-3421, 2002. 151-152, 2003.
2. National Cholesterol Education Program: Report of the expert panel 27. Mozaffarian D, Ascherio A, Hu F, et al: Interplay between different
on blood cholesterol levels in children and adolescents. (PHS-NIH polyunsaturated fatty acids and risk of coronary heart disease in men.
Publication No. 91-2731). Rockville, MD, U.S. Department of Health Circulation 111:157-164, 2005.
and Human Services, September 1991. 28. Oomen CM, Ocké MC, Feskens EJM, et al: Alpha-linolenic acid
3. Grundy SM, Cleeman JI, Merz CNB, et al: Implications of recent intake is not beneficially associated with 10-year risk of coronary
clinical trials for the National Cholesterol Education Program Adult artery disease incidence. The Zutphen Elderly Study. Am J Clin Nutr
Treatment Panel III guidelines. Circulation 110:227-239, 2004. 74:457-463, 2001.
4. Downs JR, Clearfield M, Weis S: Primary prevention of acute 29. Parks EJ, Hellerstein MK: Carbohydrate-induced
coronary events with lovastatin in men and women with average hypertriacylglycerolemia: Historical perspective and review of
cholesterol levels: Results of AFCAPS/Tex CAPS. JAMA biological mechanisms, Am J Clin Nutr 71:412-433, 2000.
279:1615-1622, 2001. 30. Howard BV, Wylie-Rosett J: Sugar and cardiovascular disease.
5. Cromwell WC, Otvos JD: Low-density lipoprotein particle number and Circulation 106:523-527, 2002.
risk for cardiovascular disease. Curr Atheroscler Rep 6:381-387, 2004. 31. Bantle JP, Raatz SK, Thomas W, et al: Effects of dietary fructose on
6. Andersen RE, Wadden TA, Bartlett SJ, et al: Relation of weight loss to plasma lipids in healthy subjects. Am J Clin Nutr 72:1128-1134,
changes in serum lipids and lipoproteins in obese women, Am J Clin 2000.
Nutr 62:350-357, 1995. 32. Foster-Powell K, Holt SHA, Brand-Miller JC: International table of
7. Schaefer EJ: Lipoproteins, nutrition, and heart disease. Am J Clin glycemic index and glycemic load values, 2002. Am J Clin Nutr
Nutr 75:191-212, 2002. 76:5-56, 2002.
~
8. Thompson PD, Buchner D, Pina IL, et al: Exercise and physical 33. Ludwig DS: The glycemic index: Physiological mechanisms relating to
activity in the prevention and treatment of atherosclerotic obesity, diabetes, and cardiovascular disease. JAMA 287:2414-2423,
cardiovascular disease. Circulation 107:3109-3116, 2003. 2002.
9. Varady KA, Jones PJH: Combination diet and exercise interventions 34. Jeppesen J, Schaaf P, Jones C, et al: Effects of low-fat, high-
for the treatment of dyslipidemia: An effective preliminary strategy to carbohydrate diets on risk factors for ischemic heart disease in
lower cholesterol levels? J Nutr 135:1829-1835, 2005. postmenopausal women. Am J Clin Nutr 65:1027-1033, 1997.
10. St. Jeor ST, Howard BV, Prewitt E, et al: Dietary protein and weight 35. Liu S, Willett WC, Stampfer MJ, et al: A prospective study of dietary
reduction. Circulation 104:1869-1874, 2001. glycemic load, carbohydrate intake, and risk of coronary heart disease
11. Dansinger ML, Gleason JA, Griffith JL, et al: Comparison of the in U.S. women. Am J Clin Nutr 71:1455-1461, 2000.
Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and 36. Position of the American Dietetic Association: Health implications of
heart disease risk reduction. JAMA 293:43-53, 2005. dietary fiber. J Am Diet Assoc 102:993-1000, 2002.
12. Camelon KM, Hadel K, Jamsen PT, et al: The plate model: A visual 37. Kerckhoffs DAJM, Brouns F, Hornstra G, et al: Effects on the human
method of teaching meal planning, J Am Diet Assoc 98:1155-1158, serum lipoprotein profile of beta-glucan, soy protein and isoflavones,
1998. plant sterols and stanols, garlic and tocotrienols. J Nutr 132:
13. de Lorgeril M, Salen P, Martin JL, et al: Mediterranean diet, 2494-2505, 2002.
traditional risk factors, and the rate of cardiovascular complications 38. Anderson JW, Hanna TJ: Whole grains and protection against
after myocardial infarction final report of the Lyon Diet Heart Study. coronary heart disease: What are the active components and
Circulation 99:779-785, 1999. mechanisms? Am J Clin Nutr 70:307-308, 1999.
14. Ornish D, Scherwitz LW, Billings JH, et al: Intensive lifestyle changes 39. Hu FB, Stampfer MJ, Manson JE, et al: Dietary protein and risk of
for reversal of coronary heart disease. JAMA 280:2001-2007, 1998 ischemic heart disease in women. Am J Clin Nutr 70:221-227, 1999.
15. Lichtenstein AH, Appel LJ, Brands M, et al: Diet and lifestyle 40. Erdman JW: Soy protein and cardiovascular disease. Circulation
recommendations revision 2006. Circulation 114:82-96, 2006. 102:2555-2559, 2000.
16. Hu FB, Willett WC: Optimal diets for prevention of coronary heart 41. Zhan S, Ho SC: Meta-analysis of the effects of soy protein containing
disease. JAMA 288:2569-2578, 2002. isoflavones on the lipid profile. Am J Clin Nutr 81:397-408, 2005.
17. Mauger J-F, Lichtenstein AH, Ausman LM, et al: Effect of different 42. Pearson TA: Alcohol and heart disease. Circulation 94:3023-3025, 1996.
forms of dietary hydrogenated fats on LDL particle size. Am J Clin 43. Goldberg IJ, Mosca L, Piano MR, et al: Wine and your heart.
© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
Nutr 78:370-375, 2003. Circulation 103:472-475, 2001.
18. Kris-Etherton P, Daniels SR, Eckel RH, et al: Summary of the 44. Ostlund RE, Racette SB, Okeke A, et al: Phytosterols that are naturally
scientific conference on dietary fatty acids and cardiovascular health. present in commercial corn oil significantly reduce cholesterol
Circulation 103:1034-1039, 2001. absorption in humans. Am J Clin Nutr 75:1000-1004, 2002.
19. Vogel JHK, Bolling SF, Costello RB, et al: Integrating complementary 45. Kris-Etherton PM, Hecker KD, Bonanome A, et al: Bioactive
medicine into cardiovascular medicine: A report of the American compounds in foods: Their role in the prevention of cardiovascular
College of Cardiology Foundation Task Force on Clinical Expert disease and cancer. Am J Med 113:71S-88S, 2002.
Consensus Document. J Am Coll Cardiol 46:184-221, 2005. 46. Kris-Etherton PM, Yu-Poth S, Sabaté J, et al: Nuts and their bioactive
20. Mensink RP, Zock PL, Kester ADM, et al:. Effects of dietary fatty constituents: Effects on serum lipids and other factors that affect
acids and carbohydrates on the ratio of serum total to HDL disease risk. Am J Clin Nutr: 70(Suppl):504S-511S, 1999.
cholesterol and on serum lipids and apolipoproteins: A meta-analysis 47. Sabaté J, Haddad E, Tanzman JS, et al: Serum lipid response to the
of 60 controlled trials. Am J Clin Nutr 77:1146-1155, 2003. graduated enrichment of a Step 1 diet with almonds: A randomized
21. German JB, Dillard CJ: Saturated fats: what dietary intake? Am J Clin feeding trial. Am J Clin Nutr 77:1379-1384, 2003.
Nutr 80:550-559, 2004. 48. Almario RU, Vonghavaravat V, Wong R, et al: Effects of walnut
22. Carson JS, Grundy SM, Van Horn L, et al: Medical nutrition therapy consumption on plasma fatty acids and lipoproteins in combined
in the prevention and management of coronary heart disease. In hyperlipidemia. Am J Clin Nutr 74:72-79, 2001.
Carson JS, Burke FM, Hark LA (eds): Cardiovascular Nutrition: 49. Morgan WA, Clayshulte BJ: Pecans lower low-density lipoprotein
Disease Management and Prevention. New York, American Dietetic cholesterol in people with normal lipid levels. J Am Diet Assoc
Association, 2004, pp 109-148. 100:312-318, 2000.
23. Connor WE: Importance of n-3 fatty acids in health and disease. 50. Kris-Etherton PM, Zhao G, Binkoski AE, et al: The effects of nuts on
Am J Clin Nutr 71(Suppl):171S-175S, 2000. coronary heart disease risk. Nutr Rev 59:103-111, 2001.
24. Bucher HC, Hengstler P, Schindler P, et al: N-3 polyunsaturated fatty 51. Ackermann RT, Mulrow CD, Ramirez G, et al: Garlic shows promise
acids in coronary heart disease: A meta-analysis of randomized for improving some cardiovascular risk factors. Arch Intern Med
controlled trials. Am J Med 112:298-304, 2002. 161:813-824, 2001.